| Product Code: ETC067379 | Publication Date: Aug 2023 | Updated Date: Sep 2025 | Product Type: Report | |
| Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The United Arab Emirates (UAE) paediatric genetic testing market has been witnessing significant growth and is poised for further expansion in the coming years. Paediatric genetic testing involves the analysis of a child`s DNA to identify genetic mutations or variations that may cause or predispose them to certain genetic disorders. In the UAE, paediatric genetic testing plays a crucial role in early disease detection, personalized treatment planning, and family planning decisions. The market`s growth is driven by factors such as the UAE focus on advancing paediatric healthcare, increasing awareness of genetic disorders, and advancements in genomic technologies.
The growth of the UAE paediatric genetic testing market is propelled by several key drivers. Firstly, the UAE government`s commitment to improving paediatric healthcare and investing in early disease detection initiatives has led to the adoption of genetic testing for children. Timely identification of genetic disorders enables early intervention and better management of these conditions. Secondly, the increasing awareness among parents and healthcare providers about the benefits of genetic testing for children has contributed to higher demand for paediatric genetic testing services in the UAE.
Despite the positive market outlook, the UAE paediatric genetic testing market faces certain challenges. One significant challenge is the need for access to comprehensive and accurate genetic databases and reference databases specific to the UAE population. Genetic testing accuracy relies on comparison with a diverse and representative dataset. Collaborations between UAE research institutions and international genetic databases can help address this challenge and improve testing accuracy. Additionally, ensuring that paediatric genetic testing services are affordable and accessible to all families in the UAE is essential to maximize the benefits of early diagnosis and intervention.
The Covid-19 pandemic, which emerged in 2025, had an impact on the UAE paediatric genetic testing market. The pandemic placed additional emphasis on preventive healthcare, including the need for early diagnosis of genetic disorders. While the pandemic initially led to disruptions in healthcare services, the UAE healthcare system quickly adapted to incorporate telemedicine and remote testing options. Paediatric genetic testing services remained essential, and telemedicine platforms facilitated consultations and result discussions, ensuring continuity of care.
The UAE paediatric genetic testing market is experiencing significant growth, driven by the country`s increasing focus on advancing childhood healthcare through early and accurate genetic diagnosis. Leading key players in this dynamic market are at the forefront of providing comprehensive paediatric genetic testing solutions, empowering healthcare professionals and parents with valuable insights into children`s genetic health. Some of the prominent companies dominating this space include Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Centogene AG, and Eurofins Scientific SE. These key players offer a wide range of paediatric genetic tests, including newborn screening panels, carrier testing, and diagnostic genetic testing, enabling early detection and personalized management of genetic disorders in children. With their dedication to research and development, genetic counselling support, and adherence to ethical guidelines, these companies are advancing paediatric healthcare in the UAE, fostering better health outcomes and improving the quality of life for children and their families.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 United Arab Emirates (UAE) Paediatric Genetic Testing Market Overview | 
| 3.1 United Arab Emirates (UAE) Country Macro Economic Indicators | 
| 3.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, 2021 & 2031F | 
| 3.3 United Arab Emirates (UAE) Paediatric Genetic Testing Market - Industry Life Cycle | 
| 3.4 United Arab Emirates (UAE) Paediatric Genetic Testing Market - Porter's Five Forces | 
| 3.5 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume Share, By Types, 2021 & 2031F | 
| 3.6 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F | 
| 4 United Arab Emirates (UAE) Paediatric Genetic Testing Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing awareness and demand for early detection of genetic disorders in children | 
| 4.2.2 Technological advancements in genetic testing leading to more accurate and affordable testing options | 
| 4.2.3 Growing investments in healthcare infrastructure and research in the UAE | 
| 4.3 Market Restraints | 
| 4.3.1 Limited insurance coverage for genetic testing procedures | 
| 4.3.2 Cultural and societal barriers impacting acceptance of genetic testing in pediatric population | 
| 4.3.3 Lack of skilled professionals and specialists in pediatric genetic testing in the UAE | 
| 5 United Arab Emirates (UAE) Paediatric Genetic Testing Market Trends | 
| 6 United Arab Emirates (UAE) Paediatric Genetic Testing Market, By Types | 
| 6.1 United Arab Emirates (UAE) Paediatric Genetic Testing Market, By Types | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Types, 2021-2031F | 
| 6.1.3 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Risk Assessment, 2021-2031F | 
| 6.1.4 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Pharmacogenomics, 2021-2031F | 
| 6.1.5 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Others, 2021-2031F | 
| 6.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market, By Applications | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By GC for Intent-to-treat Patients, 2021-2031F | 
| 6.2.3 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Paediatric Care, 2021-2031F | 
| 6.2.4 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenues & Volume, By Prenatal & Preconception Care, 2021-2031F | 
| 7 United Arab Emirates (UAE) Paediatric Genetic Testing Market Import-Export Trade Statistics | 
| 7.1 United Arab Emirates (UAE) Paediatric Genetic Testing Market Export to Major Countries | 
| 7.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Imports from Major Countries | 
| 8 United Arab Emirates (UAE) Paediatric Genetic Testing Market Key Performance Indicators | 
| 8.1 Average age of diagnosis for genetic disorders in children | 
| 8.2 Number of genetic testing facilities offering pediatric services in the UAE | 
| 8.3 Percentage of pediatric population undergoing genetic testing for potential disorders | 
| 9 United Arab Emirates (UAE) Paediatric Genetic Testing Market - Opportunity Assessment | 
| 9.1 United Arab Emirates (UAE) Paediatric Genetic Testing Market Opportunity Assessment, By Types, 2021 & 2031F | 
| 9.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Opportunity Assessment, By Applications, 2021 & 2031F | 
| 10 United Arab Emirates (UAE) Paediatric Genetic Testing Market - Competitive Landscape | 
| 10.1 United Arab Emirates (UAE) Paediatric Genetic Testing Market Revenue Share, By Companies, 2024 | 
| 10.2 United Arab Emirates (UAE) Paediatric Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |